12:00 AM
 | 
Feb 05, 2001
 |  BioCentury  |  Strategy

Onyx: It could be worse

Onyx Pharmaceuticals Inc. last week announced a solution to a problem all biotech companies wish they had: their new partner wants more than the old one did.

The great fear of biotech companies is that their deals will get dumped when a pharma partner is acquired. But ONXX had the opposite problem arise. Under a 1995 deal with

Read the full 278 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >